[go: up one dir, main page]

BR0110943A - Derivados de dissulfeto úteis para o tratamento de doenças alérgicas - Google Patents

Derivados de dissulfeto úteis para o tratamento de doenças alérgicas

Info

Publication number
BR0110943A
BR0110943A BR0110943-0A BR0110943A BR0110943A BR 0110943 A BR0110943 A BR 0110943A BR 0110943 A BR0110943 A BR 0110943A BR 0110943 A BR0110943 A BR 0110943A
Authority
BR
Brazil
Prior art keywords
treatment
disulfide derivatives
allergic diseases
derivatives useful
useful
Prior art date
Application number
BR0110943-0A
Other languages
English (en)
Inventor
Zixia Feng
Mark R Hellberg
Steven T Miller
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of BR0110943A publication Critical patent/BR0110943A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/43—Y being a hetero atom
    • C07C323/44—X or Y being nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"DERIVADOS DE DISSULFETO úTEIS PARA O TRATAMENTO DE DOENçAS ALéRGICAS". A presente invenção refere-se aos derivados de dissulfeto de difenila de fórmula (I) em que X é -NHC(=O)NH-R e R é como definido nas reivindicações são úteis para tratar ou prevenir doenças alérgicas do olho, do nariz, da pele, da orelha, do trato gastrointestinal, das vias aéreas ou do pulmão e prevenir ou tratar manifestações de mastocistose sistêmica. Os derivados de dissulfeto atuam como estabilizadores de mastócito.
BR0110943-0A 2000-05-19 2001-04-25 Derivados de dissulfeto úteis para o tratamento de doenças alérgicas BR0110943A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20582700P 2000-05-19 2000-05-19
PCT/US2001/013331 WO2001090060A1 (en) 2000-05-19 2001-04-25 Disulfide derivatives useful for treating allergic diseases

Publications (1)

Publication Number Publication Date
BR0110943A true BR0110943A (pt) 2004-01-06

Family

ID=22763799

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0110943-0A BR0110943A (pt) 2000-05-19 2001-04-25 Derivados de dissulfeto úteis para o tratamento de doenças alérgicas

Country Status (19)

Country Link
US (3) US6492552B2 (pt)
EP (1) EP1282599B1 (pt)
JP (1) JP2003534318A (pt)
KR (1) KR20030007589A (pt)
CN (2) CN1241912C (pt)
AR (1) AR028566A1 (pt)
AT (1) ATE330938T1 (pt)
AU (2) AU2001255675B2 (pt)
BR (1) BR0110943A (pt)
CA (1) CA2407964A1 (pt)
CY (1) CY1105164T1 (pt)
DE (1) DE60120961T2 (pt)
DK (1) DK1282599T3 (pt)
ES (1) ES2261402T3 (pt)
MX (1) MXPA02011481A (pt)
PL (1) PL365457A1 (pt)
PT (1) PT1282599E (pt)
WO (1) WO2001090060A1 (pt)
ZA (1) ZA200208840B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL365459A1 (en) * 2000-05-19 2005-01-10 Alcon, Inc. Aniline disulfide derivatives for treating allergic diseases
US7645903B2 (en) 2002-10-31 2010-01-12 Ge Healthcare Bio-Sciences Ab Use of urea variants as affinity ligands
EP1761259A2 (en) * 2004-06-28 2007-03-14 Alcon Inc. Topical formulations for treating allergic diseases
US20060217525A1 (en) * 2004-12-22 2006-09-28 Wright Davis Biomedical Technologies, Inc. Degradable polymers and methods of preparation thereof
KR20140043438A (ko) * 2011-06-17 2014-04-09 할로자임, 아이엔씨 히알루로난 분해 효소의 안정한 제형
US20130011378A1 (en) 2011-06-17 2013-01-10 Tzung-Horng Yang Stable formulations of a hyaluronan-degrading enzyme
FR3057264B1 (fr) 2016-10-12 2020-05-29 Arkema France Composes porteurs de groupes associatifs azotes
CN108586299B (zh) * 2018-06-06 2020-06-16 北京化工大学 一种可引发、聚合及降低体积收缩的芳香二硫化合物的制备方法及用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1232787A (pt) 1967-08-08 1971-05-19
US3663616A (en) 1969-10-13 1972-05-16 Sherwin Williams Co Bis(2-carbamylphenyl)disulfides
EP0062827B1 (en) 1978-06-16 1986-07-23 Kyowa Hakko Kogyo Co., Ltd Novel benzamide derivatives
GB8520662D0 (en) 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
US4923892A (en) 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
JPS6310784A (ja) 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
GB9020933D0 (en) 1990-09-26 1990-11-07 Ici Plc Compound,preparation and use
US5859017A (en) 1994-04-01 1999-01-12 Cell Therapeutics, Inc. Method for inhibiting mast cell and basophil activation
US5734081A (en) 1994-08-05 1998-03-31 Warner-Lambert Company Arylthio compounds
US5463122A (en) 1994-08-05 1995-10-31 Warner-Lambert Company Arylthio compounds
US6001555A (en) 1994-09-23 1999-12-14 The United States Of America As Represented By The Department Of Health And Human Services Method for identifying and using compounds that inactivate HIV-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein
JPH095926A (ja) * 1995-04-18 1997-01-10 Fuji Photo Film Co Ltd 熱現像感光材料
US5641805A (en) 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
AU2458697A (en) 1996-04-18 1997-11-07 Alcon Laboratories, Inc. Calcium channel blockers as human conjunctival mast cell degranulation inhibitors for treating ocular allergic conditions
JP2894445B2 (ja) 1997-02-12 1999-05-24 日本たばこ産業株式会社 Ｃｅｔｐ活性阻害剤として有効な化合物
JP3940201B2 (ja) 1997-05-20 2007-07-04 大塚製薬株式会社 ３，３’−ジチオジベンゾヒドロキサム酸

Also Published As

Publication number Publication date
CA2407964A1 (en) 2001-11-29
CY1105164T1 (el) 2010-03-03
WO2001090060A1 (en) 2001-11-29
US6506802B2 (en) 2003-01-14
US20020193634A1 (en) 2002-12-19
HK1050185A1 (en) 2003-06-13
DE60120961T2 (de) 2006-11-16
PL365457A1 (en) 2005-01-10
DE60120961D1 (de) 2006-08-03
CN1616422A (zh) 2005-05-18
AR028566A1 (es) 2003-05-14
DK1282599T3 (da) 2006-07-31
CN1241912C (zh) 2006-02-15
EP1282599A1 (en) 2003-02-12
CN1175807C (zh) 2004-11-17
AU2001255675B2 (en) 2005-04-14
MXPA02011481A (es) 2003-06-06
US6492552B2 (en) 2002-12-10
JP2003534318A (ja) 2003-11-18
ZA200208840B (en) 2003-12-02
ES2261402T3 (es) 2006-11-16
ATE330938T1 (de) 2006-07-15
CN1429209A (zh) 2003-07-09
KR20030007589A (ko) 2003-01-23
US20020193633A1 (en) 2002-12-19
US20020058709A1 (en) 2002-05-16
EP1282599B1 (en) 2006-06-21
US6500864B1 (en) 2002-12-31
AU5567501A (en) 2001-12-03
PT1282599E (pt) 2006-08-31

Similar Documents

Publication Publication Date Title
BR0314319A (pt) Transferência de gene mediada por vetor lentiviral e usos da mesma
CY1112444T1 (el) Χρηση των παραγωγων σουλφαμιδιου βενζο-συντηγμενου ετεροκυκλου ως νευροπροστατευτικοι παραγοντες
BR0310100A (pt) métodos para tratar, prevenir ou reduzir a lesão de reperfusão isquêmica em um tecido ou órgão, e para prevenir ou tratar de uma condição associada com a privação de oxigênio, seguida por suprimento de oxigênio aumentado a um tecido ou órgão em necessidade disto
BR9914109A (pt) Composições antibióticas para tratamento dos olhos, ouvidos e nariz
BRPI0502346A (pt) processo de tratamento cosmético para prevenir e/ou tratar as peles sensìveis e/ou secas, utilização de uma quantidade eficaz de pelo menos um microorganismo notadamente probiótico e/ou uma de suas frações e/ou um de seus metabólitos e composição cosméticas e/ou dermatológica
MY147643A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
BR0316776A (pt) Formula para anti-infeccioso tópico
BR9714677A (pt) "enantiÈmeros 3-piridila e seu uso como analgésicos"
BR0209922A (pt) Método para tratar uma condição médica que envolve a angiogênese em um paciente, para inibir a vascularização de células endoteliais, e para tratar câncer em um mamìfero
BR0110943A (pt) Derivados de dissulfeto úteis para o tratamento de doenças alérgicas
BR0016172A (pt) 4-piridinil-n-acil-l-fenilalaninas
AU2101800A (en) Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis
BR0107628A (pt) l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial
WO2007095613A3 (en) Use of benzo-heteroaryl sulfamide derivatives as neuroprotective agents
BRPI0416445A (pt) método para tratar um substrato de modo a aperfeiçoar a repelência ao álcool do substrato, substrato, tecido para controle de infecção e laminado de tecido não tramado
BR0110845A (pt) Derivados de dissulfeto de anilina para o tratamento de doenças alérgicas
EP1478660A4 (en) KAPPA-PVIIA-RELATED CONOTOXINS AS ORGAN PROTECTIVE AGENTS
CN205698232U (zh) 异形硅凝胶泡沫敷料
BR0004813A (pt) Constructos vesiculares marcados para citoproteção e tratamento de infecções por h. pylori
BR0110852A (pt) Composições que contêm um derivado dissulfeto de benzamida para tratamento de doenças alérgicas
ATE429919T1 (de) Prophylaktische und therapeutische verwendung von hydroxysteroiden
CN221450953U (zh) 一种复合式灭菌创口贴
UA96747C2 (ru) Применение бензоконденсированных гетероциклических сульфамидных производных как нейропротективных агентов
BR0205625C1 (pt) Formulações nasais em gel
WO2007131488A3 (de) Verwendung von chinolonderivaten als anti-protozoäre mittel und in kombinatinonspräparaten

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2016 DE 25/08/2009.